[Lung cancer in Spain. Current epidemiology, survival, and treatment]
- PMID: 19324488
- DOI: 10.1016/j.arbres.2008.06.005
[Lung cancer in Spain. Current epidemiology, survival, and treatment]
Abstract
In 2005, 19 115 people died of lung cancer in Spain. In spite of the increase since 1950 in absolute mortality rates, the adjusted rate for men has declined. The incidence among women is lower in Spain than in other countries but it has increased (with a ratio of 1 woman for every 8.5 men). More than 50% of the patients are over 70 years of age. While the proportion of adenocarcinomas relative to other histological types has increased worldwide, squamous cell carcinoma still predominates in Spain (ranging from 24%-50.5%). The number of patients treated by surgical resection has not increased (14.8% in Spain in 2003). Operative mortality is 6.8%. Between 25% and 50% of patients receive only palliative medication. Absolute overall survival in patients with lung cancer is under 10% in many countries. The 5-year survival rate among patients treated surgically has increased slightly, with stage IA rates ranging from 58.3% to 68.5% and stage IIIA from 28.3% to 35.8%.
Similar articles
-
Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.J Thorac Oncol. 2012 Jul;7(7):1155-63. doi: 10.1097/JTO.0b013e31824fea07. J Thorac Oncol. 2012. PMID: 22617240
-
Lung cancer in Spanish women: The WORLD07 project.Eur J Cancer Care (Engl). 2019 Jan;28(1):e12941. doi: 10.1111/ecc.12941. Epub 2018 Oct 2. Eur J Cancer Care (Engl). 2019. PMID: 30277293
-
Population-based estimates of survival benefit associated with combined modality therapy in elderly patients with locally advanced non-small cell lung cancer.J Thorac Oncol. 2011 May;6(5):934-41. doi: 10.1097/JTO.0b013e31820eed00. J Thorac Oncol. 2011. PMID: 21372743
-
[The epidemiology of lung cancer].Pneumonol Alergol Pol. 2007;75(1):76-80. Pneumonol Alergol Pol. 2007. PMID: 17541915 Review. Polish.
-
Primary cancer of the lung in women.J Natl Med Assoc. 1989 Sep;81(9):945-8. J Natl Med Assoc. 1989. PMID: 2550659 Free PMC article. Review.
Cited by
-
Prevalence of benign pulmonary lesions excised for suspicion of malignancy: could it reflect a quality management index of indeterminate lung lesions?Korean J Thorac Cardiovasc Surg. 2014 Oct;47(5):458-64. doi: 10.5090/kjtcs.2014.47.5.458. Epub 2014 Oct 5. Korean J Thorac Cardiovasc Surg. 2014. PMID: 25346901 Free PMC article.
-
Ectoenzymes and cholinesterase activity and biomarkers of oxidative stress in patients with lung cancer.Mol Cell Biochem. 2013 Feb;374(1-2):137-48. doi: 10.1007/s11010-012-1513-6. Epub 2012 Nov 18. Mol Cell Biochem. 2013. PMID: 23180243
-
Standardizing Health Outcomes for Lung Cancer. Adaptation of the International Consortium for Health Outcomes Measurement Set to the Spanish Setting.Front Oncol. 2020 Sep 2;10:1645. doi: 10.3389/fonc.2020.01645. eCollection 2020. Front Oncol. 2020. PMID: 32984036 Free PMC article.
-
A multicentre observational study of the effectiveness, safety and economic impact of nivolumab on non-small-cell lung cancer in real clinical practice.Int J Clin Pharm. 2019 Feb;41(1):272-279. doi: 10.1007/s11096-018-0772-z. Epub 2018 Dec 22. Int J Clin Pharm. 2019. PMID: 30578473
-
Pattern of use of radiotherapy for lung cancer: a descriptive study.BMC Cancer. 2014 Sep 23;14:697. doi: 10.1186/1471-2407-14-697. BMC Cancer. 2014. PMID: 25245473 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical